Domesco Medical Import - Export Joint-Stock Corporation (HOSE:DMC)
59,000
0.00 (0.00%)
At close: Apr 28, 2026
HOSE:DMC Revenue
Domesco Medical Import - Export Joint-Stock had revenue of 519.59B VND in the quarter ending March 31, 2026, with 10.76% growth. This brings the company's revenue in the last twelve months to 2.12T, up 8.64% year-over-year. In the year 2025, Domesco Medical Import - Export Joint-Stock had annual revenue of 2.07T with 8.84% growth.
Revenue (ttm)
2,117.78B
Revenue Growth
+8.64%
P/S Ratio
0.97
Revenue / Employee
2.26B
Employees
939
Market Cap
2,048.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2,067.32B | 167.89B | 8.84% |
| Dec 31, 2024 | 1,899.43B | 180.40B | 10.49% |
| Dec 31, 2023 | 1,719.03B | 126.31B | 7.93% |
| Dec 31, 2022 | 1,592.73B | 94.33B | 6.30% |
| Dec 31, 2021 | 1,498.39B | 46.44B | 3.20% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cuu Long Pharmaceutical JSC | 1,321.59B |
| OPC Pharmaceutical JSC | 1,122.99B |
| Traphaco JSC | 2,657.21B |
| Central Pharmaceutical Joint Stock Company No3 | 481.09B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Vidipha Central Pharmaceutical JSC | 971.25B |
| Binh Dinh Pharmaceutical and Medical Equipment JSC | 1,872.42B |
| Ha Tay Pharmaceutical JSC | 2,402.04B |